Andrew Callos - Net Worth and Insider Trading
Andrew Callos Net Worth
The estimated net worth of Andrew Callos is at least $2 Million dollars as of 2025-07-21. Andrew Callos is the EVP, Chief Commercial Officer of Cytokinetics Inc and owns about 52,028 shares of Cytokinetics Inc (CYTK) stock worth over $2 Million. Details can be seen in Andrew Callos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Callos has not made any transactions after 2025-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Andrew Callos
Andrew Callos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Callos owns 1 companies in total, including Cytokinetics Inc (CYTK) .
Click here to see the complete history of Andrew Callos’s form 4 insider trades.
Insider Ownership Summary of Andrew Callos
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
CYTK | Cytokinetics Inc | 2025-06-05 | EVP & Chief Commercial Officers |
Andrew Callos Latest Holdings Summary
Andrew Callos currently owns a total of 1 stock. Andrew Callos owns 52,028 shares of Cytokinetics Inc (CYTK) as of June 5, 2025, with a value of $2 Million.
Latest Holdings of Andrew Callos
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CYTK | Cytokinetics Inc | 2025-06-05 | 52,028 | 37.23 | 1,937,002 |
Holding Weightings of Andrew Callos
Andrew Callos Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Callos has made a total of 9 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Cytokinetics Inc is the sale of 8,659 shares on June 5, 2025, which brought Andrew Callos around $277,434.
Insider Trading History of Andrew Callos
- 1
Andrew Callos Trading Performance
Andrew Callos Ownership Network
Ownership Network List of Andrew Callos
Ownership Network Relation of Andrew Callos

Andrew Callos Owned Company Details
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Andrew Callos is the EVP & Chief Commercial Officers of Cytokinetics Inc. Other key executives at Cytokinetics Inc include EVP & Corp. Development & CBO Robert I Blum , SVP Research & Early Dev Fady Ibraham Malik , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Andrew Callos made 9 insider transaction in Cytokinetics Inc (CYTK) with a net sale of 70,548. Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 223,637 shares made by Fady Ibraham Malik , a net sale of 271,861 shares made by Robert I Blum , and a net sale of 40,000 shares made by B Lynne Parshall .
In summary, during the past 3 months, insiders sold 54,751 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 54,751 shares. During the past 18 months, 674,898 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 674,898 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
Andrew Callos Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Callos. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Andrew Callos's mailing address is: South San Francisco Ca 94080.